DETAILED ACTION
Notice of AIA Status
The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA .
Withdrawal of Objections and Rejections
2. Applicant's response, filed 07/21/2026, has been fully considered. In view of the amendment and remarks, the objection to the claims are withdrawn.
The following rejections and/or objections are either maintained or newly applied for claims 3, 5-7, 21 and 33-36. They constitute the complete set applied to the instant application. Herein, "the previous Office action" refers to the Final Rejection of 04/22/2026.
Continued Examination Under 37 CFR 1.114
3. A request for continued examination under 37 CFR 1.114, including the fee set forth in 37 CFR 1.17(e), was filed in this application after final rejection. Since this application is eligible for continued examination under 37 CFR 1.114, and the fee set forth in 37 CFR 1.17(e) has been timely paid, the finality of the previous Office action has been withdrawn pursuant to 37 CFR 1.114. Applicant's submission filed on 07/21/2026 has been entered.
Status of the Claims
4. Claims 1-2, 4, 8-20 and 22-32 are canceled.
Claims 3, 5-7, 21 and 33-36 are pending.
Claims 3, 5-7, 21 and 33-36 are rejected.
Priority
5. This US Application 19/340,736 (09/25/2025) is a CON of PCT/US2025/031891 (06/02/2025) which claims priority from US Application 63/655,575 (06/03/2024) and from US Application 63/803,471 (05/09/2025); as reflected in the filing receipt mailed on 10/20/2025. The claims to the benefit of priority are acknowledged, and the effective filing date of claims 3, 5-7, 21 and 33-36 is 06/03/2024.
Information Disclosure Statement
6. The information disclosure statement (IDS) submitted on 07/22/2026 was considered.
Claim Rejections - 35 USC § 112(b)
The following is a quotation of 35 U.S.C. 112(b):
(b) CONCLUSION —The specification shall conclude with one or more claims particularly pointing out and distinctly claiming the subject matter which the inventor or a joint inventor regards as the invention.
7. Claims 3, 5-7, 21 and 33-36 are rejected under 35 U.S.C. 112(b) as being indefinite for failing to particularly point out and distinctly claim the subject matter the invention. Dependent claims are rejected similarly, unless otherwise noted below. Any newly recited portions are necessitated by claim amendment. The following issues cause the respective claims to be rejected under 112(b) as indefinite:
Claim 3 recites "the group” which is indefinite because it lacks antecedent basis. The term “a group” has not been previously recited. The examiner suggests an amendment to “a group” to overcome the rejection.
Claim Rejections - 35 USC § 101
35 U.S.C. 101 reads as follows:
Whoever invents or discovers any new and useful process, machine, manufacture, or composition of matter, or any new and useful improvement thereof, may obtain a patent therefor, subject to the conditions and requirements of this title.
8. Claims 3, 5-7, 21 and 33-36 are rejected under 35 USC § 101 because the claimed inventions are directed to one or more Judicial Exceptions (JEs) without significantly more. Regarding JEs, "Claims directed to nothing more than abstract ideas..., natural phenomena, and laws of nature are not eligible for patent protection" (MPEP 2106.04 §I). Abstract ideas include mathematical concepts and procedures for evaluating, analyzing or organizing information, which are a type of mental process (MPEP 2106.04(a)(2)). Any newly recited portions are necessitated by claim amendment.
101 background
MPEP 2106 organizes JE analysis into Steps 1, 2A (Prong One & Prong Two), and 2B as analyzed below. MPEP 2106 and the following USPTO website provide further explanation and case law citations: uspto.gov/patent/laws-and-regulations/examination-policy/examination-guidance-and-training-materials.
Step 1: Are the claims directed to a process, machine, manufacture, or composition of matter (MPEP 2106.03)?
Step 2A, Prong One: Do the claims recite a judicially recognized exception, i.e., a law of nature, a natural phenomenon, or an abstract idea (MPEP 2106.04(a-c))?
Step 2A, Prong Two: If the claims recite a judicial exception under Prong One, then is the judicial exception integrated into a practical application by an additional element (MPEP 2106.04(d))?
Step 2B: Do the claims recite a non-conventional arrangement of elements in addition to any identified judicial exception(s) (MPEP 2106.05)?
Analysis of instant claims
Step 1: Are the claims directed to a 101 process, machine, manufacture, or composition of matter (MPEP 2106.03)?
The instant claims are directed to a method (claims 3, 5-7, 21 and 33-36); which falls within one of the categories of statutory subject matter.
[Step 1: claims 3, 5-7, 21 and 33-36: Yes]
Step 2A, Prong One: Do the claims recite a judicially recognized exception, i.e., a law of nature, a natural phenomenon, or an abstract idea (MPEP 2106.04(a-c))?
Background
With respect to Step 2A, Prong One, the claims recite judicial exceptions in the form of abstract ideas. MPEP § 2106.04(a)(2) further explains that abstract ideas are defined as:
• mathematical concepts (mathematical formulas or equations, mathematical relationships
and mathematical calculations) (MPEP 2106.04(a)(2)(I));
• certain methods of organizing human activity (fundamental economic principles or practices, managing personal behavior or relationships or interactions between people) (MPEP 2106.04(a)(2)(II)); and/or
• mental processes (concepts practically performed in the human mind, including observations, evaluations, judgments, and opinions) (MPEP 2106.04(a)(2)(III)).
Analysis of instant claims
With respect to the instant claims, under the Step 2A, Prong One evaluation, the claims found to recite abstract ideas that can fall into the grouping of mathematical concepts (in particular mathematical relationships and formulas) and mental processes (in particular procedures for observing, analyzing and organizing information). The identified grouping(s) for this instant claims are as follows:
Mathematical concepts (in particular mathematical relationships and formulas) include:
• "designing a mutant protein that maintains at least a first feature of a first protein while also capturing a second feature of a second protein, wherein the first feature and the second feature are independently selected from the group consisting of: protein function, protein stability, protein activity, and inclusion in a metabolic process" (independent claim 3);
• "processing each of the first protein, the second protein, and each mutant protein in the set of mutant proteins using a protein language model to generate a respective embedding of each of the first protein, the second protein, and each mutant protein in the set of mutant proteins in an embedding space" (independent claim 3);
• "determining, by the protein language model, a respective viability score for each mutant protein representing a biological likelihood of mutations reflected in the mutant protein" (independent claim 3);
• "generating a ranking of the set of mutant proteins using Pareto front optimization based on, for each mutant protein:(i) a classification of whether the embedding of the mutant protein is within a threshold conservation distance of the embedding of the first protein in the embedding space to maintain the first feature of the first protein,(ii) a distance between the embedding of the mutant protein and the embedding of the second protein to design towards the second feature of the second protein, and (iii) the viability score" (independent claim 3);
• "simultaneously optimize a microbe, a bioreactor process, and a downstream purification process" (claim 5);
• "maximize production without minimizing growth" (claim 6); and
• "increase expression without loss of activity" (claim 7).
The abstract ideas recited in the claims are evaluated under the Broadest Reasonable Interpretation (BRI) and determined to each cover performance either in the mind and/or by mathematical operation. Without further detail as to the methodology involved in "generating a respective embedding of each of the first protein, the second protein, and each mutant protein in the set of mutant proteins in an embedding space" to generate a classification and viability scoring based on the first and second proteins, under the BRI, one may simply, for example, use pen and paper to perform mathematical steps to arrive at the recited classification and viability scoring. Further support for the mathematical techniques used in the claims is provided in the specification at [0494] which describes the claimed system using processing cores to perform data transformation or integration operations; which constitutes math. Thus, the recited terms correspond to verbal equivalents of mathematical concepts because they constitute actions executed by a group of mathematical steps in a form of a mathematical algorithm; thus mathematical concepts (MPEP 2106.04(a)(2)). A mathematical concept need not be expressed in mathematical symbols, because "words used in a claim operating on data to solve a problem can serve the same purpose as a formula." In re Grams, 888 F.2d 835, 837 and n.1, 12 USPQ2d 1824, 1826 and n.1 (Fed. Cir. 1989). MPEP 2106.04(a)(2) pertains.
Mental processes, defined as concepts or steps practically performed in the human mind such as steps of observations, evaluations, judgments, analysis, opinions or organizing information include:
• "identifying a set of differing residue positions between a first protein and a second protein" (independent claim 3);
• "generating a set of mutant proteins based on the set of differing residue positions" (independent claim 3);
• " selecting one or more of the mutant proteins based on the ranking of the mutant proteins, comprising selecting one or more mutant proteins from a subset of highest ranked mutant proteins" (independent claim 3);
The human mind is also sufficiently capable of determining a protein language model, identifying a set of differing residue positions and selecting mutant proteins.
Dependent claims 33-34 and 36 recite further steps that limit the judicial exceptions in independent claims 3, 23 and 28 and, as such, also are directed to those abstract ideas. For example, claims 33-34 recite further details about the protein language model and dependent claim 36 recites further details about the generating step.
[Step 2A Prong One: claims 3, 5-7, 21 and 33-36: Yes ]
Step 2A, Prong Two: If the claims recite a judicial exception under Prong One, then is the judicial exception integrated into a practical application by an additional element (MPEP 2106.04(d))?
Background
MPEP 2106.04(d).I lists the following example considerations for evaluating whether a judicial exception is integrated into a practical application:
An improvement in the functioning of a computer or an improvement to other technology or another technical field, as discussed in MPEP §§ 2106.04(d)(1) and 2106.05(a);
Applying or using a judicial exception to effect a particular treatment or prophylaxis for a disease or medical condition, as discussed in MPEP § 2106.04(d)(2);
Implementing a judicial exception with, or using a judicial exception in conjunction with, a particular machine or manufacture that is integral to the claim, as discussed in MPEP § 2106.05(b);
Effecting a transformation or reduction of a particular article to a different state or thing, as discussed in MPEP § 2106.05(c); and
Applying or using the judicial exception in some other meaningful way beyond generally linking the use of the judicial exception to a particular technological environment, such that the claim as a whole is more than a drafting effort designed to monopolize the exception, as discussed in MPEP § 2106.05(e).
Analysis of instant claims
Instant claims 3, 21 and 34-35, recite additional elements that are not abstract ideas:
• "computationally" (independent claim 3);
• "physically synthesizing the one or more selected mutant proteins" (independent claim 3);
• "using a distributed computing architecture that parallelizes calculation of embeddings and embedding distances across a plurality of AI processing cores, wherein the AI processing cores comprise at least one of a graphics processing unit (GPU), a neural processing unit (NPU) or a field-programmable gate array (FPGA) configured with custom instruction sets for biological sequence analysis" (claim 21);
• "neural network" (claim 34);
• "wherein the neural network comprises one or more self-attention layers" (claim 35).
Considerations under Step 2A, Prong Two
The recited limitations in 3, 21 and 34-35 are interpreted as requiring the use of a computer. Hence, the claims explicitly recite steps executed by computers and therefore can be described as computer functions or instructions to implement on a generic computer. Further steps directed to additional non-abstract elements of a computing device/computer do not describe any specific computational steps by which the "computer parts" perform or carry out the judicial exceptions, nor do they provide any details of how specific structures of the computer are used to implement these functions. The claims state nothing more than a generic computer (i.e. including the recited "distributed computing architecture") which performs the functions that constitute the judicial exceptions. The instant claims state nothing more than that a generic computer performs the functions that constitute the abstract idea (MPEP 2106.05(f)).
Limitations of claims 3, 21 and 34-35 are considered to perform the claimed abstract idea with a computer, which is not sufficient to integrate an abstract idea into a practical application (see MPEP 2106.05(f)); since steps that can be performed mentally and merely performing the mental process in a computer environment do not negate the fact that something that can be carried out in the human mind. See MPEP 2106.04(a)(2).III.C.
With respect to the claims, the computer-related elements or the general purpose computer and the recited neural network model do not rise to the level of significantly more than the judicial exception. The claims state nothing more than a generic computer which performs the functions that constitute the judicial exceptions. There is no evidence of how the recited architecture improves the operation of the recited neural network itself. Using a computer to perform an abstract idea (i.e. architecture that parallelizes calculation of embeddings) is not sufficient to integrate the judicial exceptions into a practical application. Regarding the first consideration at MPEP 2106.04(d)(1), the record, including for example the specification, does not yet clearly disclose an explanation of improvement over the previous state of the technology field. The claims do not yet clearly result in such an improvement (e.g. specification: [19-20, 214, 420, 550, 561, 583, 729-905, etc.].
Hence, these are mere instructions to apply the judicial exceptions using a computer, which the courts have found to not provide significantly more when recited in a claim with a judicial exception (Alice Corp., 573 U.S. at225-26, 110 USPQ2d at 1984; see MPEP 2106.05(A)). The additional elements are set forth at such a high level of generality that they can be met by a general purpose computer. Therefore, the computer components constitute no more than a general link to a technological environment, which is insufficient to constitute an inventive concept that would render the claims significantly more than the judicial exceptions (see MPEP 2106.05(b)I-III).
Regarding the recited "physically synthesizing the one or more selected mutant proteins”, there is not sufficient evidence that the synthesized protein yields an optimized product, therefore there is no sufficient evidence that the additional element (i.e. synthesizing step) realizes the judicial exceptions (i.e. optimization scheme) into a real life practical application. (i.e. no evidence for the synthesis of an actually optimized protein due to features from first or second protein). Therefore, the recited synthesizing step reads on an apply it step.
Hence, these are mere instructions to apply the abstract idea using a computer and insignificant extra-solution activity and therefore the claims do not integrate that abstract idea into a practical application (see MPEP 2106.04(d) § I; 2106.05(f); and 2106.05(g)).
In Step 2A, Prong One above, claim steps and/or elements were identified as part of one or more judicial exceptions (JEs).
In this Step 2A, Prong Two immediately above claim steps and/or elements were identified as part of one or more additional elements. Additional elements are further discussed in Step 2B below.
Here in Step 2A, Prong Two, no additional step or element clearly demonstrates integration of the JE(s) into a practical application.
[Step 2A Prong Two: claims 3, 5-7, 21 and 33-36: No]
Step 2B: Do the claims recite a non-conventional arrangement of elements in addition to any identified judicial exception(s) (MPEP 2106.05)?
According to analysis so far, the additional elements described above do not provide significantly more than the judicial exception. A determination of whether additional elements provide significantly more also rests on whether the additional elements or a combination of elements represents other than what is well-understood, routine, and conventional. Conventionality is a question of fact and may be evidenced as: a citation to an express statement in the specification or to a statement made by an applicant during examination that demonstrates a well-understood, routine or conventional nature of the additional element(s); a citation to one or more of the court decisions as discussed in MPEP 2106(d)(II) as noting the well-understood, routine, conventional nature of the additional element(s); a citation to a publication that demonstrates the well-understood, routine, conventional nature of the additional element(s); and/or a statement that the examiner is taking official notice with respect to the well-understood, routine, conventional nature of the additional element(s).
Claims 3, 21 and 34-35 recite a computer or computer functions, interpreted as instructions to apply the abstract idea using a computer, where the computer does not impose meaningful limitations on the judicial exceptions; which can be performed without the use of a computer (MPEP 2106.04(d) § I; and MPEP 2106.05(f)).
The computer-related elements or the general purpose computer and the recited neural network model do not rise to the level of significantly more than the judicial exception. The claims state a generic computer which performs the functions that constitute the judicial exceptions. Hence, these are mere instructions to apply the judicial exceptions using a computer, which the courts have found to not provide significantly more when recited in a claim with a judicial exception (Alice Corp., 573 U.S. at225-26, 110 USPQ2d at 1984; see MPEP 2106.05(A)).
With respect to the instant claims, the prior art review to Nanda ("Searching for the Pareto frontier in multi-objective protein design." Biophysical reviews 9.4:339-344 (2017) - newly cited) discloses that “the protein synthesis and characterization of sequences that span a significant portion of the Pareto frontier in order to evaluate the relative importance of the multiple objectives” is routine, well-understood and conventional in the art. Said portions of the prior art are, for example, pg. 342 col. 2 para. 4.
When the claims are considered as a whole, they do not integrate the abstract idea into a practical application; they do not confine the use of the abstract idea to a particular technology; they do not solve a problem rooted in or arising from the use of a particular technology; they do not improve a technology by allowing the technology to perform a function that it previously was not capable of performing; and they do not provide any limitations beyond generally linking the use of the abstract idea to a broad technological environment. See MPEP 2106.05(a) and 2106.05(h).
The instant claims constitute insignificant extra solution activity, and when considered individually, are insufficient to constitute inventive concepts that would render the claims significantly more than an abstract idea (see MPEP 2106.05(g)). Hence, these elements, when considered individually, are insufficient to constitute inventive concepts that would render the claims significantly more than an abstract idea (see MPEP 2106.05(d)).
[Step 2B: claims 3, 5-7, 21 and 33-36: No]
Conclusion: Instant claims are directed to non-statutory subject matter
For the reasons above, the claims in this instant application, when the limitations are considered individually and as a whole, are directed to an abstract idea and lack an inventive concept not clearly anything significantly more.
Response to applicant's remarks in regard to Claim Rejection 35 U.S.C. ~ 101
9. The Remarks of 07/21/2026 have been fully considered but are not persuasive for the reasons below:
Applicant asserts starting in pg. 8 para. 5:
The specific configuration creates a multi-objective optimization framework that allows the system to balance competing structural constraints and biological viability more effectively than conventional techniques. By enabling this more effective focus, the claimed invention increases the likelihood that the selected candidates from the highest ranked subset possess a targeted combination of, e.g., protein function, stability, activity, or metabolic inclusion prior to physical fabrication. The step of physically synthesizing the one or more selected mutant proteins integrates the entire method into a practical application. These physical synthesis steps are not mere instructions to apply a concept; instead, they provide a direct improvement to technology by producing a physical, tangible mutant protein composition. Specifically, the nature of this improvement lies in the creation of a dual-feature protein that is designed to simultaneously maintains a first desired trait from a first protein while capturing a second desired trait from a second protein within a single viable structure. The traits are selected from the group consisting of: "protein function, protein stability, protein activity, and inclusion in a metabolic process." Furthermore, the claimed process optimizes the predictability of physical synthesis by embedding the viability score directly into the Pareto front optimization. This score reflects the biological likelihood of the mutations, filtering out unstable variants that might otherwise misfold, aggregate, or undergo degradation during the expression process. By selecting candidates that conform to these foundational constraints, the claimed process targets mutant proteins that possess the thermodynamic stability associated with stable expression. Because protein synthesis techniques are well understood when applied to such viable sequences, prioritizing candidates based on biological likelihood increases the probability that the selected mutant proteins are amenable to physical fabrication.
It is respectfully submitted that the arguments above are not persuasive because, as it appears in the claims, there is no sufficient evidence that the synthesized protein yields an optimized protein product, therefore there is no sufficient evidence that the additional element (i.e. synthesizing step) realizes the judicial exceptions into a real life practical application. (i.e. no evidence for the synthesis of an actually optimized protein due to features from first or second protein). Regarding the argued “targeted combination of, e.g., protein function, stability, activity, or metabolic inclusion prior to physical fabrication” there is no evidence that said features were realized via the recited additional elements to yield an improve protein. Therefore, the recited synthesizing step indeed reads on an apply it step.
[0019], at least, discloses that “In embodiments, defining a hit may comprise setting a threshold for minimum performance improvement over the parent strain, calculating a probability that each strain exceeds a threshold, and/or ranking strains based on their full performance distribution rather than point estimates” However, as it appears in the claims there is no evidence yet that supports a synthesized improved protein. Additionally, a there is no evidence of how the additional element argued (i.e. synthesizing step) is impacted by the additional elements (i.e. viability score). A viability score that accounts for the likelihood of a protein existing in nature may not provide evidence for a guaranteed synthesis of that same protein.
The amended claims do not solve the above described 101 issues, thus the 101 rejection is maintained. Overall, no additional step or element clearly demonstrates integration of the JE(s) into a practical application. Furthermore, the identified additional elements or the combination of elements are well understood, routine, and conventional.
Conclusion
10. No claims are allowed.
Any inquiry concerning this communication or earlier communications from the examiner should be directed to FRANCINI A FONSECA LOPEZ whose telephone number is (571)270-0899. The examiner can normally be reached Monday - Friday 8AM - 5PM ET.
Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice.
If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Olivia Wise can be reached at (571) 272-2249. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300.
Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000.
/F.F.L./Examiner, Art Unit 1685
/JANNA NICOLE SCHULTZHAUS/Examiner, Art Unit 1685